Literature DB >> 12084419

Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders.

Jose de Leon1, Francisco J Diaz, Thea Rogers, Debra Browne, Lori Dinsmore.   

Abstract

This study replicates, using more refined methodology, the indications of prior studies that patients with schizophrenia show a greater frequency of tobacco smoking than patients with mood disorders. The sample included 66 patients with schizophrenia and 51 patients with a mood disorder who were admitted at a state hospital in Kentucky. The control group included 404 community subjects. Ever daily smoking was studied using logistic regression. Survival analyses of age of onset of daily smoking (AODS) were performed controlling for several variables including education level. Nicotine dependence was measured with a scale. The prevalence of ever and current daily smoking was respectively 92 and 83% for patients with schizophrenia, 78 and 65% for patients with mood disorders, and 47 and 26% for controls. Before the age of 20, the three populations appear to have a similar risk of smoking initiation. However, after the age of 20, the initiation rate of daily smoking for patients with schizophrenia was higher than in patients with a mood disorder, or controls. Among daily smokers, there were no differences in nicotine dependence between patients with schizophrenia and those with a mood disorder. Schizophrenia was associated with a greater probability of ever daily smoking than mood disorders and with higher rates of initiation of daily smoking after 20 years old.

Entities:  

Mesh:

Year:  2002        PMID: 12084419     DOI: 10.1016/s0920-9964(01)00217-1

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  36 in total

Review 1.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Is initiation of smoking associated with the prodromal phase of schizophrenia?

Authors:  Kaisa Riala; Helinä Hakko; Matti Isohanni; Anneli Pouta; Pirkko Räsänen
Journal:  J Psychiatry Neurosci       Date:  2005-01       Impact factor: 6.186

3.  A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence.

Authors:  Ruth S Barr; Diego A Pizzagalli; Melissa A Culhane; Donald C Goff; A Eden Evins
Journal:  Biol Psychiatry       Date:  2007-11-05       Impact factor: 13.382

4.  Correlates of secondhand tobacco smoke exposure among persons with severe and persistent mental illness (SPMI) accessing community mental health services.

Authors:  Chizimuzo T C Okoli; Joy L Johnson; Leslie Malchy
Journal:  Community Ment Health J       Date:  2009-02-03

Review 5.  Smoking in schizophrenic patients: A critique of the self-medication hypothesis.

Authors:  Francesca Manzella; Susan E Maloney; George T Taylor
Journal:  World J Psychiatry       Date:  2015-03-22

6.  Cigarette smoking in obsessive-compulsive disorder and unaffected parents of OCD patients.

Authors:  Amitai Abramovitch; Diego A Pizzagalli; Daniel A Geller; Lillian Reuman; Sabine Wilhelm
Journal:  Eur Psychiatry       Date:  2014-03-14       Impact factor: 5.361

7.  Polygenic liability for schizophrenia predicts shifting-specific executive function deficits and tobacco use in a moderate drinking community sample.

Authors:  Alex P Miller; Ian R Gizer; William A Fleming Iii; Jacqueline M Otto; Joseph D Deak; Jorge S Martins; Bruce D Bartholow
Journal:  Psychiatry Res       Date:  2019-06-18       Impact factor: 3.222

8.  BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION.

Authors:  George Bartzokis
Journal:  Adolesc Psychiatry       Date:  2005

9.  Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity.

Authors:  Roman Kotov; Lin T Guey; Evelyn J Bromet; Joseph E Schwartz
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

10.  Regulation of a novel alphaN-catenin splice variant in schizophrenic smokers.

Authors:  Sharon Mexal; Ralph Berger; Lucy Pearce; Amanda Barton; Judy Logel; Catherine E Adams; Randal G Ross; Robert Freedman; Sherry Leonard
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.